Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.
Menter MA, See JA, Amend WJ, Ellis CN, Krueger GG, Lebwohl M, Morison WL, Prystowsky JH, Roenigk HH Jr, Shupack JL, Silverman AK, Weinstein GD, Yocum DE, Zanolli MD. Menter MA, et al. Among authors: weinstein gd. J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):315-21. doi: 10.1016/s0190-9622(96)80148-4. J Am Acad Dermatol. 1996. PMID: 8642106 No abstract available.
Methotrexate in psoriasis: consensus conference.
Roenigk HH Jr, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Roenigk HH Jr, et al. J Am Acad Dermatol. 1998 Mar;38(3):478-85. doi: 10.1016/s0190-9622(98)70508-0. J Am Acad Dermatol. 1998. PMID: 9520032 Review. No abstract available.
Methotrexate and psoriasis: consensus conference.
Kalb RE, Strober B, Weinstein G, Lebwohl M. Kalb RE, et al. J Am Acad Dermatol. 2011 Jun;64(6):1179. doi: 10.1016/j.jaad.2010.10.041. J Am Acad Dermatol. 2011. PMID: 21571176 No abstract available.
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS; Tazarotene Cream Clinical Study Group. Weinstein GD, et al. J Am Acad Dermatol. 2003 May;48(5):760-7. doi: 10.1067/mjd.2003.103. J Am Acad Dermatol. 2003. PMID: 12734506 Clinical Trial.
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. Lebwohl M, et al. Among authors: weinstein gd. J Am Acad Dermatol. 2008 Jan;58(1):94-105. doi: 10.1016/j.jaad.2007.08.030. Epub 2007 Nov 5. J Am Acad Dermatol. 2008. PMID: 17980456
Psoriasis.
Krueger GG, Bergstresser PR, Lowe NJ, Voorhees JJ, Weinstein GD. Krueger GG, et al. Among authors: weinstein gd. J Am Acad Dermatol. 1984 Nov;11(5 Pt 2):937-47. doi: 10.1016/s0190-9622(84)80018-3. J Am Acad Dermatol. 1984. PMID: 6389615 Review. No abstract available.
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.
Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, Jorizzo JL, Shmunes E, Tschen EH, Lew-Kaya DA, Lue JC, Sefton J, Gibson JR, Chandraratna RA. Weinstein GD, et al. J Am Acad Dermatol. 1997 Jul;37(1):85-92. doi: 10.1016/s0190-9622(97)70216-0. J Am Acad Dermatol. 1997. PMID: 9216528 Clinical Trial.
148 results